Kids' mental health drug gets extended safety check
NCT ID NCT04987229
Summary
This study follows children and teenagers with schizophrenia or bipolar I disorder who are already taking OLZ/SAM medication to check for long-term safety. Researchers want to see if side effects develop when patients take this drug combination for an extended period. The study includes 236 participants who previously completed related trials and continue to benefit from this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alkermes Investigational Site
Dothan, Alabama, 36303, United States
-
Alkermes Investigational Site
Little Rock, Arkansas, 72204, United States
-
Alkermes Investigational Site
Stanford, California, 94305, United States
-
Alkermes Investigational Site
Washington D.C., District of Columbia, 20010, United States
-
Alkermes Investigational Site
Miami Lakes, Florida, 33016, United States
-
Alkermes Investigational Site
Decatur, Georgia, 30030, United States
-
Alkermes Investigational Site
Chicago, Illinois, 60611, United States
-
Alkermes Investigational Site
Indianapolis, Indiana, 46202, United States
-
Alkermes Investigational Site
Saint Charles, Missouri, 63304, United States
-
Alkermes Investigational Site
Lincoln, Nebraska, 68526, United States
-
Alkermes Investigational Site
Cincinnati, Ohio, 45229, United States
-
Alkermes Investigational Site
West Chester, Ohio, 45069, United States
-
Alkermes Investigational Site
Richmond, Virginia, 23220, United States
-
Alkermes Investigational Site
Everett, Washington, 98201, United States
-
Alkermes Investigational Site
Ciudad Autonoma de Buenos Aire, Buenos Aires, C1181ACH, Argentina
-
Alkermes Investigational Site
La Plata, Buenos Aires, 1900, Argentina
-
Alkermes Investigational Site
Buenos Aires, Buenos Aires F.D., C1133AAH, Argentina
-
Alkermes Investigational Site
Mendoza, Mendoza Province, 5500, Argentina
-
Alkermes Investigational Site
Córdoba, X5003DCE, Argentina
-
Alkermes Investigational Site
Fortaleza, Ceará, 60430-140, Brazil
-
Alkermes Investigational Site
Curitiba, Paraná, 80240-280, Brazil
-
Alkermes Investigational Site
Rio de Janeiro, Rio de Janeiro, 22270-060, Brazil
-
Alkermes Investigational Site
São Paulo, São Paulo, 05403-010, Brazil
-
Alkermes Investigational Site
Goiânia, 74093-040, Brazil
-
Alkermes Investigational Site
São Paulo, 01228-000, Brazil
-
Alkermes Investigational Site
Barranquilla, 110121, Colombia
-
Alkermes Investigational Site
Bello, 51053, Colombia
-
Alkermes Investigational Site
Bogotá, 111166, Colombia
-
Alkermes Investigational Site
Bogotá, 80020, Colombia
-
Alkermes Investigational Site
Pereira, 660003, Colombia
-
Alkermes Investigational Site
León, Guanajuato, 37000, Mexico
-
Alkermes Investigational Site
Monterrey, Nuevo León, 64620, Mexico
-
Alkermes Investigational Site
Monterrey, Nuevo León, 64710, Mexico
-
Alkermes Investigational Site
Culiacán, Sinaloa, 80230, Mexico
-
Alkermes Investigational Site
Gustavo A. Madero, State of Mexico, C.P. 07000, Mexico
-
Alkermes Investigator Site
Denver, Colorado, 80202, United States
Conditions
Explore the condition pages connected to this study.